ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ADCT ADC Therapeutics SA

4.10
0.01 (0.24%)
May 17 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
ADC Therapeutics SA ADCT NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.01 0.24% 4.10 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.09 4.00 4.175 4.10 4.09
more quote information »

Recent News

Date Time Source Heading
5/17/202411:00IHNWFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
5/15/202407:15GLOBEADC Therapeutics to Participate in the H.C. Wainwright 2nd..
5/14/202412:32EDGAR2Form 8-K - Current report
5/09/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202407:15GLOBEADC Therapeutics to Participate in 2024 RBC Capital Markets..
5/08/202416:07EDGAR2Form 8-K - Current report
5/07/202416:06EDGAR2Form 144 - Report of proposed sale of securities
5/07/202416:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/06/202407:30GLOBEADC Therapeutics Announces $105 Million Underwritten..
5/06/202406:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/06/202406:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/06/202406:29EDGAR2Form 8-K - Current report
5/06/202406:10GLOBEADC Therapeutics Reports First Quarter 2024 Financial..
5/06/202406:00GLOBEADC Therapeutics Announces Initial Data from..
5/01/202416:05GLOBEADC Therapeutics Makes Grants to New Employees Under..
5/01/202407:00GLOBEADC Therapeutics to Host First Quarter 2024 Financial..
4/04/202407:00GLOBEADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial..
4/03/202407:00GLOBEADC Therapeutics to Host a Virtual Research Investor Event..
4/01/202416:05GLOBEADC Therapeutics Makes Grants to New Employees Under..
3/13/202407:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
3/13/202407:00GLOBEADC Therapeutics Reports Fourth Quarter and Full Year 2023..
3/06/202407:15GLOBEADC Therapeutics to Participate in the Guggenheim 5th Annual..
3/06/202407:00GLOBEADC Therapeutics to Host Fourth Quarter and Year-End 2023..
3/05/202417:45GLOBEADC Therapeutics Announces Abstracts Accepted for..
3/05/202409:15EDGAR2Form 8-K - Current report
2/29/202416:30EDGAR2Form 8-K - Current report
2/27/202407:00GLOBEADC Therapeutics to Participate in the TD Cowen 44th Annual..
1/24/202408:00EDGAR2Form 8-K - Current report
1/19/202416:30EDGAR2Form 8-K - Current report
1/04/202407:15EDGAR2Form 8-K - Current report
1/04/202407:15GLOBEADC Therapeutics Regains Compliance with NYSE Continued..
1/04/202407:00EDGAR2Form 8-K - Current report
1/04/202407:00GLOBEADC Therapeutics Provides Business Updates
1/02/202420:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/02/202420:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/02/202420:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/02/202420:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/02/202419:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/02/202419:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/19/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/18/202316:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/12/202305:15GLOBEADC Therapeutics Announces Initial Results from..
12/04/202316:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/20/202302:40PRNUSSobi to present new data at ASH 2023 Annual Meeting
11/15/202303:00GLOBEMyricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur..
11/07/202307:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/202307:15GLOBEADC Therapeutics Receives NYSE Notice of Non-Compliance With..
11/07/202307:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/202307:00GLOBEADC Therapeutics Reports Third Quarter 2023 Financial..
11/06/202307:00GLOBEADC Therapeutics to Participate in the Jefferies London..
11/02/202310:10GLOBEADC Therapeutics Announces Abstracts Accepted for..

Your Recent History

Delayed Upgrade Clock